logo
episode-header-image
Jul 2023
14m 27s

AAN President Elect Testified Before Hou...

AMERICAN ACADEMY OF NEUROLOGY
About this episode

Dr. Stacey Clardy talks with Dr. Natalia Rost about her experience speaking before the House of Representatives on the approval of lecanemab for the treatment of early Alzheimer disease.

Visit NPUb.org/Podcast for associated article links.

This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

Up next
Aug 6
The Current State of Diagnostics for Neuroimmunologic Disorders in Africa
Dr. Paul Crane talks with Drs. Fiifi Duodu and Malya Sahu about neuroimmunology and multiple sclerosis diagnosis in Africa, including challenges and efforts to improve care. Read the related article here. Disclosures can be found at Neurology.org. 
21m 59s
Aug 3
Ampreloxetine for Neurogenic Orthostatic Hypotension in MSA
Dr. Elizabeth Coon talks with Dr. Lucy Norcliffe-Kaufmann about the mechanism-based therapy with ampreloxetine for neurogenic orthostatic hypotension in multiple system atrophy, highlighting recent clinical trial results and future directions. Read the related article in Neurolog ... Show More
22m 9s
Aug 1
August 2026 Recall: Topics in Headache
The August 2026 recall showcases five incredible interviews highlighting recent advances in headache medicine. The episode begins with Dr. Patricia Pozo-Rosich discussing the latest advancements in headache medicine, focusing on key research findings from 2025. The episode contin ... Show More
1h 50m
Recommended Episodes
Jun 2025
Advancing Radiology for Early Alzheimer's Detection - Sponsored by Eli Lilly and Company
<p>In this episode, Dr. Ashwin Parihar speaks with Dr. Petrice Cogswell about the radiologist's critical role in diagnosing Alzheimer's disease and how imaging advances are reshaping early detection. They also explore how innovation at scale, platform thinking, and operational al ... Show More
20m 44s
Jun 2023
SOS Minute: Autoimmune Encephalitis
Drs. Stacey Clardy and Fabio Nascimento discuss the case of a patient with Autoimmune Encephalitis. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. 
4m 26s
Nov 2023
Alzheimer’s Update, Part 2
This episode explores the current state of research on the multiple likely mechanisms of Alzheimer’s disease as well as promising treatments and diagnostics. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2309944. 
54 m
Dec 2024
156| Updated Diagnosis and Staging Criteria for Alzheimer's Disease – A Conversation with Dr. Cliff Jack and Dr. Kevin Duff
<p class="MsoNormal">This episode is a conversation with Drs. Clifford Jack and Kevin Duff about recent updates to the diagnosis and staging of Alzheimer's disease (AD). We discuss biological versus clinical/pathological approaches to diagnosing AD, analogies between AD and other ... Show More
1h 44m
Apr 2024
Dementia News Roundup - Frankly Speaking Ep 378
<p>Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-378'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-378</a></p> <p>Overview: Effective treatmen ... Show More
10m 37s
Mar 2024
Lecanemab in Alzheimer Disease
<p>Dr. Jason Crowell talks with Dr. Anelyssa D' Abreu about her recently posted NeuroByte on key features in Lecanemab. </p> <p>Watch the <a href="https://learning.aan.com/courses/62800" target="_blank" rel="noopener">NeuroByte now</a>! </p> 
4 m
Sep 2024
The Dual Advantage: Improving Alzheimer Care with Combination Therapy - Frankly Speaking Ep 399
<p>Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-399'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-399</a></p> <p>Overview: In this episode, w ... Show More
10m 17s
Aug 2023
Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease
<p>In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews considerations for their use in patients with Alzheimer disease.<br /> <br /> <stron ... Show More
28m 48s
Feb 2024
The 2 Minute Medicine® Podcast- Episode 35
<p>We begin with a discussion about our article of the week which comes from The Lancet and is entitled “Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-c ... Show More
11m 48s
Sep 2024
Neuroimaging in the Era of Anti-Amyloid Therapies - Sponsored by GE HealthCare
Dr. Linda Chu speaks with Dr. Giuseppe Esposito, Dr. Yasar Torres-Yaghi, and Dr. Lydia Wood to explore how the availability of amyloid PET imaging and other advanced neuroimaging techniques is transforming the diagnostic and treatment landscape for neurodegenerative disorders. Sp ... Show More
50m 15s